XML 18 R9.htm IDEA: XBRL DOCUMENT v3.21.1
Restatement of Previously Issued Financial Statements
12 Months Ended
Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS

NOTE 2. RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS

 

The Company previously accounted for its outstanding Public Warrants (as defined in Note 5) and Private Placement Warrants issued in connection with its Initial Public Offering as components of equity instead of as derivative liabilities. The warrant agreement governing the warrants includes a provision that provides for potential changes to the settlement amounts dependent upon the characteristics of the holder of the warrant. In addition, the warrant agreement includes a provision that in the event of a tender or exchange offer made to and accepted by holders of more than 50% of the outstanding shares of a single class of common shares, all holders of the warrants would be entitled to receive cash for their warrants (the "tender offer provision").

 

In connection with the audit of the Company's financial statements for the period ended December 31, 2020, the Company's management further evaluated the warrants under Accounting Standards Codification ("ASC") Subtopic 815-40, Contracts in Entity's Own Equity.  ASC Section 815-40-15 addresses equity versus liability treatment and classification of equity-linked financial instruments, including warrants, and states that a warrant may be classified as a component of equity only if, among other things, the warrant is indexed to the issuer's common stock.  Under ASC Section 815-40-15, a warrant is not indexed to the issuer's common stock if the terms of the warrant require an adjustment to the exercise price upon a specified event and that event is not an input to the fair value of the warrant.  Based on management's evaluation, the Company's audit committee, in consultation with management, concluded that the Company's Private Placement Warrants are not indexed to the Company's common shares in the manner contemplated by ASC Section 815-40-15 because the holder of the instrument is not an input into the pricing of a fixed-for-fixed option on equity shares. In addition, based on management's evaluation, the Company's audit committee, in consultation with management, concluded the tender offer provision included in the warrant agreement fails the "classified in shareholders' equity" criteria as contemplated by ASC Section 815-40-25.

 

As a result of the above, the Company should have classified the warrants as derivative liabilities in its previously issued financial statements. Under this accounting treatment, the Company is required to measure the fair value of the warrants at the end of each reporting period and recognize changes in the fair value from the prior period in the Company's operating results for the current period.

 

The Company's accounting for the warrants as components of equity instead of as derivative liabilities did not have any effect on the Company's previously reported operating expenses, cash flows or cash.

 

   As         
   Previously       As 
   Reported   Adjustments   Restated 
             
Balance sheet as of September 19, 2019 (audited)            
Total Liabilities  $13,150,815   $23,999,950   $37,150,765 
Class A Common Stock Subject to Possible Redemption   333,314,490    (23,999,950)   309,314,540 
Class A Common Stock   248    240    488 
Additional Paid-in Capital   5,002,945    988,003    5,990,948 
Accumulated Deficit   (4,065)   (988,243)   (992,308)
Total Stockholders' Equity   5,000,003        5,000,003 
                
Number of Class A common stock subject to redemption   33,331,449    (2,399,995)   30,931,454 
                
Balance sheet as of September 30, 2019 (unaudited)               
Total Liabilities  $13,284,099   $23,829,000   $37,113,099 
Class A Common Stock Subject to Possible Redemption   333,347,150    (23,829,000)   309,518,150 
Class A Common Stock   248    238    486 
Additional Paid-in Capital   4,970,285    817,055    5,787,340 
(Accumulated Deficit) Retained Earnings   28,595    (817,293)   (788,698)
Total Stockholders' Equity   5,000,003        5,000,003 
                
Number of Class A common stock subject to redemption   33,334,715    (2,382,900)   30,951,815 
                
Balance sheet as of December 31, 2019 (audited)               
Total Liabilities  $13,768,244   $20,947,150   $34,715,394 
Class A Common Stock Subject to Possible Redemption   334,219,360    (20,947,150)   313,272,210 
Class A Common Stock   239    209    448 
Additional Paid-in Capital   4,098,084    (2,064,766)   2,033,318 
Retained Earnings   900,810    2,064,558    2,965,368 
Total Stockholders' Equity   5,000,008        5,000,008 
                
Number of Class A common stock subject to redemption   33,421,936    (2,094,715)   31,327,221 
                
Balance sheet as of March 31, 2020 (unaudited)               
Total Liabilities  $14,063,126   $16,653,150   $30,716,276 
Class A Common Stock Subject to Possible Redemption   335,035,050    (16,653,150)   318,381,900 
Class A Common Stock   231    166    397 
Additional Paid-in Capital   3,282,402    (6,358,723)   (3,076,321)
Retained Earnings   1,716,495    6,358,557    8,075,052 
Total Stockholders' Equity   5,000,003        5,000,003 
                
Number of Class A common stock subject to redemption   33,503,505    (1,665,315)   31,838,190 
                
Balance sheet as of June 30, 2020 (unaudited)               
Total Liabilities  $14,082,333   $30,863,750   $44,946,083 
Class A Common Stock Subject to Possible Redemption   334,879,810    (30,863,750)   304,016,060 
Class A Common Stock   232    309    541 
Additional Paid-in Capital   3,437,641    7,851,734    11,289,375 
(Accumulated Deficit) Retained Earnings   1,561,255    (7,852,043)   (6,290,788)
Total Stockholders' Equity   5,000,003        5,000,003 
                
Number of Class A common stock subject to redemption   33,487,981    (3,086,375)   30,401,606 
                
Balance sheet as of September 30, 2020 (unaudited)               
Total Liabilities  $13,252,231    35,173,100    48,425,331 
Class A Common Stock Subject to Possible Redemption   334,703,480    (35,173,100)   299,530,380 
Class A Common Stock   234    352    586 
Additional Paid-in Capital   3,613,969    12,161,041    15,775,010 
(Accumulated Deficit) Retained Earnings   1,384,926    (12,161,393)   (10,776,467)
Total Stockholders' Equity   5,000,004        5,000,004 
                
Number of Class A common stock subject to redemption   33,470,348    (3,517,310)   29,953,038 
                
Balance sheet as of December 31, 2020 (audited)               
Total Liabilities  $17,639,744   $77,419,100   $95,058,844 
Class A Common Stock Subject to Possible Redemption   329,968,280    (77,419,100)   252,549,180 
Class A Common Stock   281    775    1,056 
Additional Paid-in Capital   8,349,122    54,406,617    62,755,739 
Accumulated Deficit   (3,350,275)   (54,407,392)   (57,757,667)
Total Stockholders' Equity   5,000,003        5,000,003 
                
Number of Class A common stock subject to redemption   32,996,828    (7,741,910)   25,254,918 
                
Three months ended September 30, 2019 (unaudited)               
Net income (loss)  $29,595   $(817,293)  $(787,698)
Weighted average shares outstanding of Class A and Class B non-redeemable common stock   8,855,652    -    8,855,652 
Basic and diluted net loss per share, Class A and Class B non-redeemable common stock   0.00    (0.10)   (0.10)
                
                
Period from April 5, 2019 (inception) to September 30, 2019 (unaudited)               
Net income (loss)  $28,595   $(817,293)  $(788,698)
Weighted average shares outstanding of Class A and Class B non-redeemable common stock   8,804,607    -    8,804,607 
Basic and diluted net loss per share, Class A and Class B non-redeemable common stock   0.00    (0.10)   (0.10)
                
Period from April 5, 2019 (inception) to December 31, 2019 (audited)               
Net income (loss)  $900,810   $2,064,558   $2,965,368 
Weighted average shares outstanding of Class A and Class B non-redeemable common stock   9,062,000    -    9,062,000 
Basic and diluted net loss per share, Class A and Class B non-redeemable common stock   (0.03)   0.23    0.20 
                
                
Three months ended March 31, 2020 (unaudited)               
Net income (loss)  $815,685    4,294,000   $5,109,685 
Weighted average shares outstanding of Class A and Class B non-redeemable common stock   9,560,000    -    9,560,000 
Basic and diluted net loss per share, Class A and Class B non-redeemable common stock   (0.02)   0.45    0.43 
                
Three months ended June 30, 2020 (unaudited)               
Net income (loss)  $(155,240)   (9,916,600)  $(10,071,840)
Weighted average shares outstanding of Class A and Class B non-redeemable common stock   9,560,000    -    9,560,000 
Basic and diluted net loss per share, Class A and Class B non-redeemable common stock   (0.02)   (1.04)   (1.06)
                
Six months ended June 30, 2020 (unaudited)               
Net income (loss)  $660,445   $(9,916,600)  $(9,256,155)
Weighted average shares outstanding of Class A and Class B non-redeemable common stock   9,560,000    -    9,560,000 
Basic and diluted net loss per share, Class A and Class B non-redeemable common stock   (0.04)   (1.04)   (1.08)
                
Three months ended September 30, 2020 (unaudited)               
Net income (loss)   (176,329)   (14,225,950)   (14,402,279)
Weighted average shares outstanding of Class A and Class B non-redeemable common stock   9,560,000    -    9,560,000 
Basic and diluted net loss per share, Class A and Class B non-redeemable common stock   (0.02)   (1.49)   (1.51)
                
Nine months ended September 30, 2020 (unaudited)               
Net income (loss)  $484,116   $(14,225,950)  $(13,741,834)
Weighted average shares outstanding of Class A and Class B non-redeemable common stock   9,560,000    -    9,560,000 
Basic and diluted net loss per share, Class A and Class B non-redeemable common stock   (0.06)   (1.49)   (1.55)
                
                
Year ended December 31, 2020 (audited)               
Net income (loss)  $(4,251,085)  $(56,471,950)  $(60,723,035)
Weighted average shares outstanding of Class A and Class B non-redeemable common stock   9,560,000    -    9,560,000 
Basic and diluted net loss per share, Class A and Class B non-redeemable common stock   (0.56)   (5.90)   (6.46)